Johnson & Johnson (JNJ)

Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell

$153.55

Buy

$153.58

arrow-up$0.34 (+0.22%)

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.
Prices updated at 05 Jun 2025, 17:41 EDT
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-up0.2%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Income statement

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
76,450m81,581m82,059m82,584m78,740m79,990m85,159m88,821m
51,011m54,490m54,503m54,157m55,338m55,394m58,606m61,350m
18,897m21,175m20,970m19,733m20,943m21,013m23,409m22,149m
24.7225.9625.5523.8926.6026.2727.4924.94
1,300m15,297m15,119m14,714m20,878m17,941m35,153m14,066m
24,249m25,933m24,655m23,929m26,751m26,605m23,320m24,781m
Sales, General and administrative21,520m22,540m22,178m22,084m20,118m20,246m20,112m21,969m
Interest expenses934m1,005m318m201m183m276m772m755m
Provision for income taxes16,373m2,702m2,209m1,783m1,377m2,989m1,736m2,621m
Operating expenses32,114m33,315m33,533m34,424m34,395m34,381m35,197m39,201m
Income before taxes17,673m17,999m17,328m16,497m19,178m19,359m15,062m16,687m
Net income available to common shareholders1,300m15,297m15,119m14,714m20,878m17,941m35,153m14,066m
0.485.75.725.597.936.8313.885.84
Net interest income-549m-394m39m-90m-130m214m489m577m
Advertising and promotion--------
Net investment income, net--------
Realised capital gains (losses), net--------
Total benefits, claims and expenses--------
Earnings per share (diluted)0.475.615.635.517.816.7313.725.79
Free cash flow per share6.7146.75897.30516.85328.40126.64716.01617.8293
Book value/share27.578124.274322.11224.490826.69328.53329.591129.1484
Debt equity ratio0.509890.4633150.4454940.515740.4050770.350060.376320.428745

Balance sheet

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
Current assets43,088m46,033m45,274m51,237m60,979m55,294m53,495m55,893m
Current liabilities30,537m31,230m35,964m42,493m45,226m55,802m46,282m50,321m
Total capital90,835m87,436m85,965m95,913m104,008m103,692m94,655m102,141m
Total debt34,581m30,480m27,696m35,266m33,751m39,659m29,332m36,634m
Total equity60,160m59,752m59,471m63,278m74,023m76,804m68,774m71,490m
Total non current liabilities--------
Loans30,675m27,684m26,494m32,635m29,985m26,888m25,881m30,651m
Total assets157,303m152,954m157,728m174,894m182,018m187,378m167,558m180,104m
Total liabilities--------
Cash and cash equivalents17,824m18,107m17,305m13,985m14,487m14,127m21,859m24,105m
Common stock2,683m2,662m2,633m2,633m2,629m2,614m2,407m2,407m

Cash flow

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
Cash at beginning of period18,972m17,824m18,107m17,305m13,985m14,487m14,127m21,859m
Cash dividends paid-8,943m-9,494m-9,917m-10,481m-11,032m-11,682m-11,770m-11,823m
17,777m18,531m19,918m20,189m19,758m17,185m17,778m18,059m
Investments (gains) losses-14,868m-3,167m-6,194m-20,825m-8,683m-12,371m878m-18,599m
17,824m18,107m17,305m13,985m14,487m14,127m21,859m24,105m
Net income--------
21,056m22,201m23,416m23,536m23,410m21,194m22,791m24,266m
-3,279m-3,670m-3,498m-3,347m-3,652m-4,009m-5,013m-6,207m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.